MICHAEL PERRY: Open Payments
NPI 1356385470 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,208 in 142 payments from 20 companies in 2025. Trend: 2023 $2,839 · 2024 $2,991 · 2025 $3,208
Food & beverage: $3,208
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $695 |
| LEO Pharma Inc. | 22 | $517 |
| Janssen Biotech, Inc. | 22 | $488 |
| GENZYME CORPORATION | 13 | $439 |
| PFIZER INC. | 11 | $188 |
| Novartis Pharmaceuticals Corporation | 6 | $140 |
| Organon LLC | 11 | $98 |
| Incyte Corporation | 4 | $84 |
| Regeneron Healthcare Solutions, Inc. | 4 | $81 |
| E.R. Squibb & Sons, L.L.C. | 4 | $73 |
Products named: DUPIXENT, RINVOQ, TREMFYA, ADBRY, ANZUPGO, SKYRIZI, CIBINQO, OPZELURA.
Industry payments across FL — which companies pay providers there.
